OOIR: Observatory of International Research

Papers

(The median citation count of Retrovirology is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)

Article	Citations
P-selectin glycoprotein ligand-1 (PSGL-1/CD162) is incorporated into clinical HIV-1 isolates and can mediate virus capture and subsequent transfer to permissive cells	56
Partial waivers: PEPFAR’s 2025 funding suspension and the looming HIV/AIDS catastrophe in Sub-Saharan Africa	51
CRISPR/Cas9 genome editing to create nonhuman primate models for studying stem cell therapies for HIV infection	35
HERVK-mediated regulation of neighboring genes: implications for breast cancer prognosis	33
Derivation and characterization of an HIV-1 mutant that rescues IP6 binding deficiency	31
HIV-1 integrase binding to genomic RNA 5′-UTR induces local structural changes in vitro and in virio	27
Diverse antiviral IgG effector activities are predicted by unique biophysical antibody features	26
A gut check: understanding the interplay of the gastrointestinal microbiome and the developing immune system towards the goal of pediatric HIV remission	26
HIV-1 infection of renal epithelial cells: 30 years of evidence from transgenic animal models, human studies and in vitro experiments	21
HIV-1 subtype C Nef-mediated SERINC5 down-regulation significantly contributes to overall Nef activity	21
Neutralization diversity of HIV-1 Indian subtype C envelopes obtained from cross sectional and followed up individuals against broadly neutralizing monoclonal antibodies having distinct gp120 specific	20
The KT Jeang retrovirology prize 2023: Thumbi Ndung’u	20
The chemokine receptor CCR5: multi-faceted hook for HIV-1	17
Pericyte infection by HIV-1: a fatal attraction	14
Simon Litvak (1942–2022)	13
Intestinal endothelial cells increase HIV infection and latency in resting and activated CD4 + T cells, particularly affecting CCR6 + CD4 + T cells	13
Opposing roles of CLK SR kinases in controlling HIV-1 gene expression and latency	12
HIV infection of non-classical cells in the brain	12
Transmitted/founder SHIV.D replicates in the brain, causes neuropathogenesis, and persists on combination antiretroviral therapy in rhesus macaques	12
Cocaine augments neuro-inflammation via modulating extracellular vesicle release in HIV-1 infected immune cells	12
HIV-2/SIV Vpx antagonises NF-κB activation by targeting p65	11
Innate immune regulation in HIV latency models	11
A clinical review of HIV integrase strand transfer inhibitors (INSTIs) for the prevention and treatment of HIV-1 infection	11
Comparative analysis of retroviral Gag-host cell interactions: focus on the nuclear interactome	10
Declining trend of HTLV-1 among organ/ tissue donors in Iranian Tissue Bank between 2014–2021	10

A large population sample of African HIV genomes from the 1980s reveals a reduction in subtype D over time associated with propensity for CXCR4 tropism	9
The KT Jeang retrovirology prize 2024: Walther Mothes	9
Defective HIV-1 genomes and their potential impact on HIV pathogenesis	9
HIVIntact: a python-based tool for HIV-1 genome intactness inference	8
Rotten to the core: antivirals targeting the HIV-1 capsid core	8
Dysregulation of the tumor suppressor Menin and its target Bach2 in HTLV-1 infection	8
A novel class III endogenous retrovirus with a class I envelope gene in African frogs with an intact genome and developmentally regulated transcripts in Xenopus tropicalis	7
Shared and unique patterns of autonomous human endogenous retrovirus loci transcriptomes in CD14 + monocytes from individuals with physical trauma or infection with COVID-19	7
A complex network of transcription factors and epigenetic regulators involved in bovine leukemia virus transcriptional regulation	7
The key amino acid sites 199–205, 269, 319, 321 and 324 of ALV-K env contribute to the weaker replication capacity of ALV-K than ALV-A	7
Bone marrow stromal antigen 2 (BST-2) genetic variants influence expression levels and disease outcome in HIV-1 chronically infected patients	6
Therapeutic efficacy of albuvirtide-based antiretroviral therapy in people living with HIV who have low-level viremia and non-AIDS-defining malignancies: two case reports	6
Arginyl-tRNA-protein transferase 1 contributes to governing optimal stability of the human immunodeficiency virus type 1 core	6
Interview with a Retrovirologist: Sebla B. Kutluay in conversation with Carol Carter	6
Correction: Analysis of PERV-C superinfection resistance using HA-tagged viruses	6
Editorial Expression of Concern: Exceptional molecular and coreceptor-requirement properties of molecular clones isolated from an human immunodeficiency virus Type-1 subtype C infection	5
Addressing an HIV cure in LMIC	5
A detailed analysis of F-MuLV- and SFFV-infected cells in Friend virus-infected mice reveals the contribution of both F-MuLV- and SFFV-infected cells to the interleukin-10 host response	5
Analysis of PERV-C superinfection resistance using HA-tagged viruses	5
Interview with a Retrovirologist: Wibke Bayer in conversation with Hung Fan	5
Anti-inflammatory effects of recreational marijuana in virally suppressed youth with HIV-1 are reversed by use of tobacco products in combination with marijuana	5
Altered Env conformational dynamics as a mechanism of resistance to peptide-triazole HIV-1 inactivators	5
An endogenous lentivirus in the germline of a rodent	4
Advancing our understanding of HIV co-infections and neurological disease using the humanized mouse	4
Correction to: A novel Betaretrovirus discovered in cattle with neurological disease and encephalitis	4
Comprehensive identification and characterization of the HERV-K (HML-9) group in the human genome	4
Repression of HIV-1 reactivation mediated by CRISPR/dCas9-KRAB in lymphoid and myeloid cell models	4
Replication-competent HIV-1 in human alveolar macrophages and monocytes despite nucleotide pools with elevated dUTP	4
Bovine leukemia virus (BLV) and risk of breast cancer; a systematic review and meta-analysis	4
Biomolecular condensates: insights into early and late steps of the HIV-1 replication cycle	4
Immunoescape of HIV-1 in Env-EL9 CD8 + T cell response restricted by HLA-B*14:02 in a Non progressor who lost twenty-seven years of HIV-1 control	4
Impact of HIV-1 CRF55_01B infection on the evolution of CD4 count and plasma HIV RNA load in men who have sex with men prior to antiretroviral therapy	4